Publications

Nature cancer

Publisher Correction: Long-distance modulation of bystander tumor cells by CD8⁺ T-cell-secreted IFN-γ.

01-07-2020

Nature immunology

Author Correction: Tissue patrol by resident memory CD8⁺ T cells in human skin.

01-06-2020

Communications biology

A mouse model that is immunologically tolerant to reporter and modifier proteins.

29-05-2020

Immunity

The CD47-SIRPα Immune Checkpoint.

19-05-2020

Cancer immunology research

Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.

01-05-2020

Nature medicine

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

01-04-2020

Nature reviews. Cancer

CD8⁺ T cell states in human cancer: insights from single-cell analysis.

01-04-2020

Proceedings of the National Academy of Sciences of the United States of America

CD29 identifies IFN-γ-producing human CD8⁺ T cells with an increased cytotoxic potential.

24-03-2020

Nature cancer

Long-distance modulation of bystander tumor cells by CD8⁺ T cell-secreted IFNγ.

01-03-2020

Immunity

Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics.

18-02-2020

Nature protocols

Tumor organoid-T-cell coculture systems.

01-01-2020

Nature

B cells and tertiary lymphoid structures promote immunotherapy response.

01-01-2020

Nature communications

Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

26-11-2019

Nature reviews. Immunology

Defining 'T cell exhaustion'.

01-11-2019

Nature communications

Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

01-11-2019

Cell

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.

25-07-2019

The Lancet. Oncology

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

01-07-2019

Nature medicine

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

01-07-2019

Nature immunology

Tissue patrol by resident memory CD8⁺ T cells in human skin.

01-06-2019

Nature protocols

Induction of neoantigen-reactive T cells from healthy donors.

01-06-2019

Nature medicine

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

01-06-2019

Annual review of immunology

Cancer Neoantigens.

26-04-2019

Nature communications

Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer.

24-04-2019

Cancer immunology research

Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity.

01-04-2019

Cancer immunology research

Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells.

01-04-2019

Nature medicine

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy.

01-04-2019

Nature communications

Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer.

15-02-2019

PloS one

SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing.

13-02-2019

Cell

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

07-02-2019

Nature medicine

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers.

01-01-2019

Nature biotechnology

T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexes.

19-11-2018

Nature medicine

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.

01-11-2018

Cell

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.

06-09-2018

ImmunoHorizons

Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8⁺ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection.

02-07-2018

Nature medicine

A transcriptionally and functionally distinct PD-1⁺ CD8⁺ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade.

01-07-2018

Cancer cell

T Cell Dysfunction in Cancer.

09-04-2018

Immunity

Regulation and Function of the PD-L1 Checkpoint.

20-03-2018

Cell

Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes.

25-01-2018

eLife

The Human Cell Atlas.

05-12-2017

JCO precision oncology

Profound Immunotherapy Response in Mismatch Repair-Deficient Breast Cancer.

01-11-2017

Nature biotechnology

Antigen receptor repertoire profiling from RNA-seq data.

11-10-2017

European journal of immunology

Guidelines for the use of flow cytometry and cell sorting in immunological studies.

01-10-2017

Nature

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.

07-09-2017

Cancer research

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling.

01-09-2017

Cancer immunology, immunotherapy : CII

HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.

01-09-2017

Cancer research

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors.

01-02-2017

JAMA oncology

Genomics- and Transcriptomics-Based Patient Selection for Cancer Treatment With Immune Checkpoint Inhibitors: A Review.

01-11-2016

Methods in molecular biology (Clifton, N.J.)

pMHC Multiplexing Strategy to Detect High Numbers of T Cell Responses in Parallel.

28-10-2016

The Journal of experimental medicine

Preventing tumor escape by targeting a post-proteasomal trimming independent epitope.

17-10-2016

The New England journal of medicine

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

01-09-2016

Publisher Correction: Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ.

Author Correction: Tissue patrol by resident memory CD8+ T cells in human skin.

A mouse model that is immunologically tolerant to reporter and modifier proteins.

The CD47-SIRPα Immune Checkpoint.

Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

CD8+ T cell states in human cancer: insights from single-cell analysis.

CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential.

Long-distance modulation of bystander tumor cells by CD8+ T cell-secreted IFNγ.

Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics.

Tumor organoid-T-cell coculture systems.

B cells and tertiary lymphoid structures promote immunotherapy response.

Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

Defining 'T cell exhaustion'.

Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

Tissue patrol by resident memory CD8+ T cells in human skin.

Induction of neoantigen-reactive T cells from healthy donors.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

Cancer Neoantigens.

Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer.

Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity.

Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells.

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy.

Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer.

SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing.

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers.

T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexes.

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.

Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection.

A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade.

T Cell Dysfunction in Cancer.

Regulation and Function of the PD-L1 Checkpoint.

Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes.

The Human Cell Atlas.

Profound Immunotherapy Response in Mismatch Repair-Deficient Breast Cancer.

Antigen receptor repertoire profiling from RNA-seq data.

Guidelines for the use of flow cytometry and cell sorting in immunological studies.

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling.

HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors.

Genomics- and Transcriptomics-Based Patient Selection for Cancer Treatment With Immune Checkpoint Inhibitors: A Review.

pMHC Multiplexing Strategy to Detect High Numbers of T Cell Responses in Parallel.

Preventing tumor escape by targeting a post-proteasomal trimming independent epitope.

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

This site uses cookies

Publisher Correction: Long-distance modulation of bystander tumor cells by CD8⁺ T-cell-secreted IFN-γ.

Author Correction: Tissue patrol by resident memory CD8⁺ T cells in human skin.

CD8⁺ T cell states in human cancer: insights from single-cell analysis.

CD29 identifies IFN-γ-producing human CD8⁺ T cells with an increased cytotoxic potential.

Long-distance modulation of bystander tumor cells by CD8⁺ T cell-secreted IFNγ.

Tissue patrol by resident memory CD8⁺ T cells in human skin.

Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8⁺ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection.

A transcriptionally and functionally distinct PD-1⁺ CD8⁺ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade.